Hers review

Hers for mothers: our verdict

⛔ An FDA warning letter dated September 2025, over the compounded-semaglutide business it has since left behind. One of the few mass-market brands designed around a woman's front door — now selling FDA-approved brand Wegovy and Zepbound instead of the compounded semaglutide it used to, though the posted price is only half the bill once the required $149/mo membership is added. It runs about $149/month — toward the affordable end of what we track.

We weigh Hers the way mothers actually have to: not just the monthly cost, but postpartum and breastfeeding timing and PCOS and insulin resistance — the parts a general weight-loss roundup leaves out.

What Hers costs, in full

• Brand-name semaglutide — Wegovy Pill (oral): $149/mo
• Brand-name semaglutide — Wegovy Pen (injectable): $199/mo
• Brand-name tirzepatide — Zepbound (vial or KwikPen): $299/mo

That sits below the roughly $179 median ongoing price across the providers we track for mothers — a real cost advantage.

Hers says the price covers the provider visit, and that the medication is billed separately. That is the comparison that matters at this price: two providers a few dollars apart can differ by a hundred a month once the extras are counted, so line up what each one bundles before you decide.

The medications Hers prescribes

Hers prescribes semaglutide and tirzepatide — the two with the largest published weight-loss effects, and carrying both on one account matters when insulin resistance, common with PCOS and after gestational diabetes, makes tirzepatide the better-suited option. Brand pens are available here alongside the compounded versions, and the on-label products come with the manufacturer's own pregnancy and lactation labeling — easier to hand to an OB.

A needle-free oral or sublingual option is on the menu, which draws in mothers who've been avoiding injections — just set expectations: oral and buccal delivery of these peptides is far less studied than the injectable versions the trials used.

Where Hers fits — and where it doesn't — for mothers

A good fit if…

• the monthly cost is a real barrier and you want a low, predictable number.
• switching between semaglutide and tirzepatide may become necessary as your body and your hormones change.
• uninterrupted nationwide access matters — a move for family shouldn't interrupt care.

Look elsewhere if…

• a clean regulatory record is a dealbreaker — note the FDA warning flagged in the cons above.
• you'd rather a prescriber talk through timing around postpartum and breastfeeding timing — that is the ground our #1 pick, CoreAge Rx, is built on.

Oversight, safety, and what we could verify

Everything Hers states publicly checked out at last review: pricing, pharmacies and clinical network were all verifiable. It carries an FDA warning letter, flagged in the cons — read it before starting. As with any compounded GLP-1, the most useful thing mothers can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our scoring methodology.

A standing caveat for mothers: GLP-1 medications aren't established as safe during pregnancy or breastfeeding, and every label advises against use. Nothing here changes that — plan the timing with your own clinician.

The bottom line

Hers is a provider we list only with full disclosure — weigh it on postpartum and breastfeeding timing and PCOS and insulin resistance against the alternatives below. For most mothers, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.